Clinikally Secures $2.6M in Seed Funding to Transform Dermatology Care in India

Clinikally, a dynamic startup founded in 2021 by Arjun Soin, has successfully raised $2.6 million in seed funding to revolutionize dermatology care in India. The company's ambitious mission is to establish itself as the go-to telemedicine platform and online pharmacy for individuals seeking personalized dermatological treatments.

Dermatological issues such as acne, hair loss, Androgenetic Alopecia, hyperpigmentation, eczema, rosacea, and melasma affect millions of people worldwide. Clinikally recognized the need for accessible and personalized care in this field and embarked on a journey to bridge the gap.

Clinikally's innovative platform acts as a connecting bridge between individuals and highly qualified dermatologists. Through this platform, users can receive expert guidance and tailored treatment plans for their specific skin concerns. Whether it's a persistent acne problem or hair loss concerns, Clinikally offers comprehensive solutions to address these issues.

One of the standout features of Clinikally is its strategic partnerships with pharmacies and consumer brands. This collaboration allows Clinikally to provide prescription-grade skincare, haircare, and wellness products. Beyond dermatological concerns, the platform extends its offerings to include products related to immunity and nutrition, catering to the holistic well-being of its users.

What truly sets Clinikally apart is its integration of cutting-edge AI technology into its e-pharmacy. This AI-powered system offers recommendations for select over-the-counter (OTC) products. These recommendations are based on individual diagnoses and specific conditions, streamlining the process of creating automated treatment plans.

Headquartered in Gurugram, Clinikally has rapidly expanded its reach and made its mark across 500 cities in India. In a relatively short span of time, the company has served more than 450,000 users, earning their trust through its commitment to quality care and innovative solutions.

The $2.6 million seed funding secured by Clinikally represents a significant milestone in the company's journey. It will be instrumental in further enhancing its services, expanding its reach, and advancing its technological capabilities. With a strong focus on dermatology care, Clinikally is poised to make a lasting impact on the healthcare sector in India.

In conclusion, Clinikally's mission to render dermatology care more accessible and personalized aligns with the evolving healthcare landscape. By leveraging telemedicine, e-pharmacy services, and AI-powered recommendations, Clinikally is well-positioned to lead the way in transforming dermatological care in India. With its commitment to innovation and user-centric solutions, the future looks promising for this dynamic startup.



InsightX Newsletter for latest Update /Don’t worry, it’s 100% free